Neuropeptides
Volume 44, Issue 3 , Pages 233-239 , June 2010

Acoustic startle response and sensorimotor gating in a genetic mouse model for the Y1 receptor

  • T. Karl

      Affiliations

    • Neuroscience Research Program, Garvan Institute of Medical Research, Sydney, NSW 2010, Australia
    • Schizophrenia Research Institute (SRI), Sydney, NSW 2010, Australia
    • Prince of Wales Medical Research Institute, Sydney, NSW 2031, Australia
    • Corresponding Author InformationCorresponding author. Address: Prince of Wales Medical Research Institute, Corner Barker Street and Easy Street, Randwick (Sydney), NSW 2031, Australia. Tel./fax: +61 2 9399 1005.
    • Authors contributed equally to this work.
    • ,
  • R. Chesworth

      Affiliations

    • Neuroscience Research Program, Garvan Institute of Medical Research, Sydney, NSW 2010, Australia
    • Schizophrenia Research Institute (SRI), Sydney, NSW 2010, Australia
    • Prince of Wales Medical Research Institute, Sydney, NSW 2031, Australia
    • Authors contributed equally to this work.
    • ,
  • L. Duffy

      Affiliations

    • Neuroscience Research Program, Garvan Institute of Medical Research, Sydney, NSW 2010, Australia
    • Schizophrenia Research Institute (SRI), Sydney, NSW 2010, Australia
    • ,
  • H. Herzog

      Affiliations

    • Neuroscience Research Program, Garvan Institute of Medical Research, Sydney, NSW 2010, Australia

Received 30 June 2009 ,Accepted 11 December 2009.

References 

  1. Bannon AW, Seda J, Carmouche M, Francis JM, Norman MH, Karbon B, et al. Behavioural characterization of neuropeptide Y knockout mice. Brain Res. 2000;868:79–87
  2. Beal MF, Svendsen CN, Bird ED, Martin JB. Somatostatin and neuropeptide Y are unaltered in the amygdala in schizophrenia. Neurochem. Pathol. 1987;6:169–176
  3. Braff DL, Geyer MA, Swerdlow NR. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl). 2001;156:234–258
  4. Choi KH, Elashoff M, Higgs BW, Song J, Kim S, Sabunciyan S, et al. Putative psychosis genes in the prefrontal cortex: combined analysis of gene expression microarrays. BMC Psychiatry. 2008;8:87
  5. Csomor PA, Yee BK, Vollenweider FX, Feldon J, Nicolet T, Quednow BB. On the influence of baseline startle reactivity on the indexation of prepulse inhibition. Behav. Neurosci. 2008;122:885–900
  6. Curran C, Byrappa N, McBride A. Stimulant psychosis: systematic review. Br. J. Psychiatry. 2004;185:196–204
  7. Gabriel SM, Davidson M, Haroutunian V, Powchik P, Bierer LM, Purohit DP, et al. Neuropeptide deficits in schizophrenia vs. Alzheimer’s disease cerebral cortex. Biol. Psychiatry. 1996;39:82–91
  8. Geyer MA, Braff DL. Habituation of the blink reflex in normals and schizophrenic patients. Psychophysiology. 1982;19:1–6
  9. Geyer MA, Krebs-Thomson K, Braff DL, Swerdlow NR. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology (Berl). 2001;156:117–154
  10. Howell OW, Scharfman HE, Herzog H, Sundstrom LE, Beck-Sickinger A, Gray WP. Neuropeptide Y is neuroproliferative for post-natal hippocampal precursor cells. J. Neurochem. 2003;86:646–659
  11. Husum H, Termeer E, Mathe AA, Bolwig TG, Ellenbroek BA. Early maternal deprivation alters hippocampal levels of neuropeptide Y and calcitonin-gene related peptide in adult rats. Neuropharmacology. 2002;42:798–806
  12. Ikeda K, Ikeda K, Iritani S, Ueno H, Niizato K. Distribution of neuropeptide Y interneurons in the dorsal prefrontal cortex of schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2004;28:379–383
  13. Itokawa M, Arai M, Kato S, Ogata Y, Furukawa A, Haga S, et al. Association between a novel polymorphism in the promoter region of the neuropeptide Y gene and schizophrenia in humans. Neurosci. Lett. 2003;347:202–204
  14. Karl T, Lin S, Schwarzer C, Sainsbury A, Couzens M, Wittmann W, et al. Y1 receptors regulate aggressive behavior by modulating serotonin pathways. Proc. Natl. Acad. Sci. USA. 2004;101:12742–12747
  15. Karl T, Burne TH, Herzog H. Effect of Y1 receptor deficiency on motor activity, exploration, and anxiety. Behav. Brain Res. 2006;167:87–93
  16. Kishi T, Aschkenasi CJ, Choi BJ, Lopez ME, Lee CE, Liu H, et al. Neuropeptide Y Y1 receptor mRNA in rodent brain: distribution and colocalization with melanocortin-4 receptor. J. Comp. Neurol. 2005;482:217–243
  17. Koch M. The neurobiology of startle. Prog. Neurobiol. 1999;59:107–128
  18. Kuromitsu J, Yokoi A, Kawai T, Nagasu T, Aizawa T, Haga S, et al. Reduced neuropeptide Y mRNA levels in the frontal cortex of people with schizophrenia and bipolar disorder. Gene Expr. Patterns. 2001;1:17–21
  19. Lindberg C, Koefoed P, Hansen ES, Bolwig TG, Rehfeld JF, Mellerup E, et al. No association between the −399°C>T polymorphism of the neuropeptide Y gene and schizophrenia, unipolar depression or panic disorder in a Danish population. Acta Psychiatr. Scand. 2006;113:54–58
  20. Naveilhan P, Neveu I, Arenas E, Ernfors P. Complementary and overlapping expression of Y1, Y2 and Y5 receptors in the developing and adult mouse nervous system. Neuroscience. 1998;87:289–302
  21. Sachs GS. A review of agitation in mental illness: burden of illness and underlying pathology. J. Clin. Psychiatry. 2006;67(Suppl. 10):5–12
  22. Swerdlow NR, Braff DL, Geyer MA. Animal models of deficient sensorimotor gating: what we know, what we think we now, and what we hope to know soon. Behav. Pharmacol. 2000;11:185–204
  23. Tschenett A, Singewald N, Carli M, Balducci C, Salchner P, Vezzani A, et al. Reduced anxiety and improved stress coping ability in mice lacking NPY-Y2 receptors. Eur. J. Neurosci. 2003;18:143–148
  24. van den Buuse M, Garner B, Gogos A, Kusljic S. Importance of animal models in schizophrenia research. Aust. N. Z. J. Psychiatry. 2005;39:550–557
  25. Varty GB, Walters N, Cohen-Williams M, Carey GJ. Comparison of apomorphine, amphetamine and dizocilpine disruptions of prepulse inhibition in inbred and outbred mice strains. Eur. J. Pharmacol. 2001;424:27–36
  26. Vawter MP, Ferran E, Galke B, Cooper K, Bunney WE, Byerley W. Microarray screening of lymphocyte gene expression differences in a multiplex schizophrenia pedigree. Schizophr. Res. 2004;67:41–52
  27. Wang JH, Short J, Ledent C, Lawrence AJ, van den Buuse M. Reduced startle habituation and prepulse inhibition in mice lacking the adenosine A2A receptor. Behav. Brain Res. 2003;143:201–207
  28. Wittmann W, Loacker S, Kapeller I, Herzog H, Schwarzer C. Y1-receptors regulate the expression of Y2-receptors in distinct mouse forebrain areas. Neuroscience. 2005;136:241–250
  29. Yee BK, Chang DL, Feldon J. The effects of dizocilpine and phencyclidine on prepulse inhibition of the acoustic startle reflex and on prepulse-elicited reactivity in C57BL6 mice. Neuropsychopharmacology. 2004;29:1865–1877

PII: S0143-4179(09)00147-4

doi: 10.1016/j.npep.2009.12.008

Neuropeptides
Volume 44, Issue 3 , Pages 233-239 , June 2010

Article Tools

* Image Usage & Resolution